Regulation of Toll-like Receptor 4 by ISO-1 in HUVECs

HAN Ye-ming,JANG Shi-qin,ZHANG Chao
2010-01-01
Abstract:Objective To study the effect of ISO-1 [(S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid methyl ester],a specific antagonist of MIF(Macrophage migration inhibition factor),on TLR4(Toll-like receptor) activities in HUVEC(Human umbilical vein endothelial cells),and to provide experimental evidence for the treatment of TLR4-related diseases in which ISO-1 is targeted.Methods HUVECs were cultured and divided into 4 groups: the LPS(lipid polysaccharide) group,the ISO-1 pretreatment group,the LPS+ISO-1 group and the Medium control group.Effects of ISO-1 on TLR4 expression,TNFα(tumor necrosis factor) and NOS(nitric oxide synthase) secretion were investigated with RT-PCR,immunofluorescense staining,radioimmunoassay and enzyme-chemical reactions.Results Expression of TLR4 in HUVEC was obviously inhibited by pretreatment with high concentration of ISO-1,especially in the 25 and 50 μmol/L groups(P0.05).Low expression of TLR4 was also detected at 0.5,1,2 and 3 h after pretreatment with 50 μmol/L ISO-1,in which the lowest appeared at 1h(P0.05).Immunofluorescense showed a low level TLR4 in normal HUVEC,however,expression could be enhanced by LPS(10 ng/mL).TLR4 expression,TLR4-induced TNFα and NOS secretion were markedly suppressed 1h after the pretreatment with 50 μmol/L ISO-1,and such inhibition was dose dependent(P0.05).The effective time of ISO-1 was short and the maximal was at 1 h.Conclusion ISO-1 can exert inhibitory effects through down-regulating the TLR4 activities of HUVEC,which suggests that ISO-1 may be a potential target-agent in the treatment of TLR4-related diseases,such as atherosclerosis and inflammation.
What problem does this paper attempt to address?